Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

Organogenesis宣布计划通过与位于罗德岛史密斯菲尔德的100 Technology Way的生物制造设施签订长期租约来扩大制造业-半导体产能

Benzinga · 2024/11/23 05:09

Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.

Organogenesis控股公司（纳斯达克：ORGO），一家领先的再生医学公司，专注于开发、制造和商业化在Advanced Wound Care和手术及体育医学市场产品解决方案，宣布计划通过租赁长期租约，扩大在罗德岛史密斯菲尔德市100 Technology Way的122,000平方英尺最先进的生物制造设施的制造能力。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

风险及免责提示

声明